Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1279924 | 0.87 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL11612420 | 0.83 | MEN1 (0.44) | MEN1KMT2ATDP1 | |
| SCHEMBL8402370 | 0.83 | MEN1 (0.44) | MEN1KMT2ATDP1 | |
| SCHEMBL27997087 | 0.78 | MEN1 (0.47) | MEN1KMT2ATDP1 | |
| SCHEMBL10354566 | 0.76 | MEN1 (0.37) | MEN1KMT2ATDP1 | |
| SCHEMBL25327648 | 0.75 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL10186548 | 0.75 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL9803044 | 0.75 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL144465 | 0.75 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL1279986 | 0.75 | MEN1 (0.50) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065326-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2002-05-30 | — | — | US | claimed |
| US-5914352-A | Methods for the use of stabilized fluorocarbon emulsions | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-06-22 | — | — | US | claimed |
| US-5628930-A | STORAGE STABILITY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-05-13 | — | — | US | claimed |
| EP-0666736-A1 | STABILIZATION OF FLUOROCARBON EMULSIONS. | ALLIANCE PHARMA (US) | 1995-08-16 | — | — | EP | claimed |
| WO-1994009625-A2 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-05-11 | — | — | WO | claimed |
| US-10590381-B2 | Composition for collecting and preserving placental stem cells and methods of using the composition | Celularity, Inc. (US) | 2020-03-17 | — | — | US | disclosed |
| US-20170327788-A1 | COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION (US) | 2017-11-16 | — | — | US | disclosed |
| US-9725694-B2 | Composition for collecting and preserving placental stem cells and methods of using the composition | ANTHROGENESIS CORPORATION (US) | 2017-08-08 | — | — | US | disclosed |
| US-9598669-B2 | Composition for collecting placental stem cells and methods of using the composition | ANTHROGENESIS CORPORATION (US) | 2017-03-21 | — | — | US | disclosed |
| US-20100291679-A1 | COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION | 2010-11-18 | — | — | US | disclosed |
| EP-1974013-A2 | IMPROVED COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | Anthrogenesis Corporation (US) | 2008-10-01 | — | — | EP | disclosed |
| US-20070190042-A1 | Composition for collecting and preserving placental stem cells and methods of using the composition | Celularity, Inc. | 2007-08-16 | — | — | US | disclosed |
| WO-2007079185-A2 | IMPROVED COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION (US) | 2007-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190042-A1 | Composition for collecting and preserving placental stem cells and methods of using the composition | PGF, ALPP, CPA1 | MEN1 3150/4885KMT2A 3422/4885TDP1 838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.